Medline Inc.

Medline Inc.

Surgical & medical instruments

Company website
Foundation year

1966

Close date

1/25/2026

Profitability

55.38%

About

Medline Inc. is the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. The company delivers mission-critical products used daily across a full spectrum of care settings, including hospitals, surgery centers, physician offices, and post-acute facilities. Through its two segments, Medline Brand and Supply Chain Solutions, Medline Inc. offers approximately 335,000 med-surg products. These include surgical and procedural kits, gloves and protective apparel, urological and incontinence care products, wound care products, and consumable laboratory and diagnostic supplies.

Medline Inc. holds leading positions across several of its end markets and key product categories. The company distributes its products through an extensive network of 69 global distribution facilities, encompassing more than 29 million square feet of warehouse space, along with a fleet of over 2,000 MedTrans trucks. This infrastructure enables next-day delivery to 95% of its U.S. customers. The company’s integrated business model and customer-centric culture drive lower costs and greater value for its stakeholders. As a result, Medline Inc. has established a durable recurring revenue base, with net sales growing every year since the company’s inception at a compound annual growth rate (“CAGR”) of 18%.

Underwriters

Goldman Sachs, Morgan Stanley, BofA Securities, J.P. Morgan


2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.